Efficacy of bronchoscopy-guided <sup>125</sup>I seeds implantation combined with chemotherapy for advanced central type lung cancer _Chinese Journal of Respiratory and Critical Care Medicine

Authors：

 LIN Hui ¹ , SU Xianghua ² ,  XIAO Jianhong ¹

1. Respiratory Department, Mindong Hospital Affiliated to Fujian Medical University, Fu’an, Fujian 355000, P. R. China;
2. Neurosurgery Department, Mindong Hospital Affiliated to Fujian Medical University, Fu’an, Fujian 355000, P. R. China;

Corresponding?author：

XIAO Jianhong, Email: xjh1030@sina.com

Keywords：

Electronic bronchoscopy; Lung neoplasms; Radioactive particles ¹²⁵I; Chemotherapy

DOI：

10.7507/1671-6205.201701022

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To explore the efficacy and safety of bronchoscopy-guided radioactive ¹²⁵I seeds implantation combination with chemotherapy for advanced central type lung cancer. Methods Sixty-six patients with central type lung cancer in stage Ⅲb or Ⅳ were enrolled in this study from May 2014 to July 2016. The patients were randomly divided into two groups, ie. bronchoscopy-guided seeds implantation combined with chemotherapy group (experimental group, n=30) and chemotherapy group (control group, n=36). All patients accepted GP regimen (gemcitabine plus cisplatin) chemotherapy and were followed up by CT and electric bronchoscopy (EB) examination 1, 3, 5 months later. According to WHO unified standard, the efficacy and adverse effects were evaluated . Results In the experimental group and the control group, the response rate (complete response plus partial response) was 80.00% and 50.00%, respectively. There was significant difference between two groups (P<0.05). The incidence rate of hemoptysis in the experimental group was significantly higher than that in the control group (P<0.05), but there was no significant difference between the two groups in the incidence rate of pneumothorax, fever or bone marrow suppression (allP>0.05). All adverse reactions were light and could be controlled. Conclusions The short-term clinical efficacy is better in the bronchoscopy-guided seeds implantation combined with chemotherapy group. The bronchoscopy-guided seeds implantation combined with chemotherapy is a safe and minimally invasive treatment for advanced central type lung cancer.

Citation： LIN Hui, SU Xianghua, XIAO Jianhong. Efficacy of bronchoscopy-guided ¹²⁵I seeds implantation combined with chemotherapy for advanced central type lung cancer . Chinese Journal of Respiratory and Critical Care Medicine, 2017, 16(6): 567-570. doi: 10.7507/1671-6205.201701022 Copy

1.	Zheng R, Zeng H, Zhang S, et al. National estimates of cancer prevalence in China, 2011. Cancer Lett, 2016, 370(1): 33-38.
2.	Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
3.	Chen W, Zheng R, Baade PD, et al. Cancer statistics in china 2015.CA Cancer J Clin, 2016, 66(2): 115-132.
4.	李真斌, 湯曉梅, 易向軍, 等. 電子支氣管鏡介導冷凍治療聯合放化療治療中晚期中央型 NSCLC 的臨床研究. 中國醫學創新, 2014, 11(36): 27-29.
5.	柯明耀, 吳雪梅, 林玉妹, 等. 經支氣管鏡置入支架及植入放射性粒子治療肺癌中心氣管狹窄. 中國內鏡雜志, 2009, 15(3): 240-245.
6.	柯明耀, 姜燕, 王珠緞, 等. 經支氣管鏡植入放射性粒子治療晚期中心型肺癌.臨床肺科雜志, 2006, 11(2): 247-248.
7.	張旭, 岳世昌, 趙翌. 手術加 ¹²⁵I 粒子植入治療肺癌的初步評價. 實用醫學雜志, 2005, 21(4): 375.
8.	張福君, 李傳行, 吳沛宏, 等. ¹²⁵I 粒子組織間植入治療局部晚期肺癌的對比研究. 中華醫學雜志, 2007, 86(47): 3272-3275.
9.	李力軍, 馬林, 呂大鵬, 等. 現代高新技術治療惡性腫瘤. 北京: 人民軍醫出版社, 2003, 133-155.
10.	蔣美萍, 劉粉霞, 金紅艷, 等. 局部中晚期非小細胞肺癌同步與序貫放化療的療效對比. 數理醫藥學雜志, 2010, 23(1): 57-58.
11.	周明, 王遠東, 凌國輝, 等. 重組人血管內皮抑素與化療聯合治療肺癌的時序性研究. 中華實驗外科雜志, 2011, 28(10): 1743-1745.
12.	張明川, 梅同華, 厲明, 等. 持續小劑量化療對 A549 肺癌生長及 VE-Cadherin 的影響. 腫瘤防治研究, 2011, 38(6): 624-627.
13.	Furuse K, Fukuoka M, Kawahara M, et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage Ⅲ non-small-cell lung cancer. J Clin Oncol, 1999, 17(9): 2692.
14.	Neg S, Ellis RJ, Merrick GS, et al. American Brachytherapy Society Commendation for reporting morbidity after prostate brachytherapy. In J Radiat Biol Phys, 2002, 54(2): 462-470.
15.	李玉亮, 王永正, 張福君. CT 引導下經皮穿刺植入 ¹²⁵I 粒子治療老年中心型肺癌近期療效分析. 中華腫瘤防治雜志, 2007, 14(23): 1818-1820.
16.	焦德超, 張福君, 陸酈工, 等. ¹²⁵I 粒子組織間植入治療肺惡性腫瘤. 介入放射學雜志, 2008, 17(3): 190-193.
17.	胡曉坤, 王明友, 楊國志, 等. CT 導引經皮穿刺組織間植入 ¹²⁵I 放射微粒子治療中心型肺癌的應用研究. 中華放射學雜志, 2004, 38(9): 910-915.
18.	馬海濤, 吳翼偉, 秦涌, 等. 姑息性切除加術中 ¹²⁵I 種子源植入治療晚期非小細胞肺癌. 中華核醫學雜志, 2003, 23(6): 342-343.
19.	余紅波, 崔亞利, 郭雨棟. ¹²⁵I 粒子與放療分別聯合化療治療Ⅲb 期 NSCLC 的比較. 實用腫瘤學雜志, 2008, 22(1): 23.

1. Zheng R, Zeng H, Zhang S, et al. National estimates of cancer prevalence in China, 2011. Cancer Lett, 2016, 370(1): 33-38.
2. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin, 2015, 65(2): 87-108.
3. Chen W, Zheng R, Baade PD, et al. Cancer statistics in china 2015.CA Cancer J Clin, 2016, 66(2): 115-132.
4. 李真斌, 湯曉梅, 易向軍, 等. 電子支氣管鏡介導冷凍治療聯合放化療治療中晚期中央型 NSCLC 的臨床研究. 中國醫學創新, 2014, 11(36): 27-29.
5. 柯明耀, 吳雪梅, 林玉妹, 等. 經支氣管鏡置入支架及植入放射性粒子治療肺癌中心氣管狹窄. 中國內鏡雜志, 2009, 15(3): 240-245.
6. 柯明耀, 姜燕, 王珠緞, 等. 經支氣管鏡植入放射性粒子治療晚期中心型肺癌.臨床肺科雜志, 2006, 11(2): 247-248.
7. 張旭, 岳世昌, 趙翌. 手術加 ¹²⁵I 粒子植入治療肺癌的初步評價. 實用醫學雜志, 2005, 21(4): 375.
8. 張福君, 李傳行, 吳沛宏, 等. ¹²⁵I 粒子組織間植入治療局部晚期肺癌的對比研究. 中華醫學雜志, 2007, 86(47): 3272-3275.
9. 李力軍, 馬林, 呂大鵬, 等. 現代高新技術治療惡性腫瘤. 北京: 人民軍醫出版社, 2003, 133-155.
10. 蔣美萍, 劉粉霞, 金紅艷, 等. 局部中晚期非小細胞肺癌同步與序貫放化療的療效對比. 數理醫藥學雜志, 2010, 23(1): 57-58.
11. 周明, 王遠東, 凌國輝, 等. 重組人血管內皮抑素與化療聯合治療肺癌的時序性研究. 中華實驗外科雜志, 2011, 28(10): 1743-1745.
12. 張明川, 梅同華, 厲明, 等. 持續小劑量化療對 A549 肺癌生長及 VE-Cadherin 的影響. 腫瘤防治研究, 2011, 38(6): 624-627.
13. Furuse K, Fukuoka M, Kawahara M, et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage Ⅲ non-small-cell lung cancer. J Clin Oncol, 1999, 17(9): 2692.
14. Neg S, Ellis RJ, Merrick GS, et al. American Brachytherapy Society Commendation for reporting morbidity after prostate brachytherapy. In J Radiat Biol Phys, 2002, 54(2): 462-470.
15. 李玉亮, 王永正, 張福君. CT 引導下經皮穿刺植入 ¹²⁵I 粒子治療老年中心型肺癌近期療效分析. 中華腫瘤防治雜志, 2007, 14(23): 1818-1820.
16. 焦德超, 張福君, 陸酈工, 等. ¹²⁵I 粒子組織間植入治療肺惡性腫瘤. 介入放射學雜志, 2008, 17(3): 190-193.
17. 胡曉坤, 王明友, 楊國志, 等. CT 導引經皮穿刺組織間植入 ¹²⁵I 放射微粒子治療中心型肺癌的應用研究. 中華放射學雜志, 2004, 38(9): 910-915.
18. 馬海濤, 吳翼偉, 秦涌, 等. 姑息性切除加術中 ¹²⁵I 種子源植入治療晚期非小細胞肺癌. 中華核醫學雜志, 2003, 23(6): 342-343.
19. 余紅波, 崔亞利, 郭雨棟. ¹²⁵I 粒子與放療分別聯合化療治療Ⅲb 期 NSCLC 的比較. 實用腫瘤學雜志, 2008, 22(1): 23.

Chinese Journal of Respiratory and Critical Care Medicine

Efficacy of bronchoscopy-guided ¹²⁵I seeds implantation combined with chemotherapy for advanced central type lung cancer

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content

Chinese Journal of Respiratory and Critical Care Medicine

Efficacy of bronchoscopy-guided 125I seeds implantation combined with chemotherapy for advanced central type lung cancer

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content

Efficacy of bronchoscopy-guided ¹²⁵I seeds implantation combined with chemotherapy for advanced central type lung cancer